Hogan Lovells Events | 18 May 2023 | 8:30 a.m. - 4:00 p.m. (EDT)

AI Health Law & Policy Summit

Hogan Lovells hosted our annual AI Health Law & Policy Summit on Thursday, 18 May 2023. This was an informative and interactive program where our thought leaders and industry guests addressed a variety of topics including new and emerging health care AI policies and regulatory considerations, implications for ethics and consumer safety, developments in the EU, and more.

Recordings from the summit are available to watch below.

• AI Data Privacy


• AI Dealmaking


• Global AI Trends


• Market Access Landscape


• Regulating Evolving AI Technologies

External Speakers

• Michael Abramoff, MD, Founder & Executive Chairman, Digital Diagnostics
• Samantha Ashley, Manager, CPT, American Medical Association
• Laurent Audoly, President and CEO of Ruptakine, Inc.
• Laura P. Coombs, PhD, Vice President, Data Science & Informatics, American College of Radiology
• Tess Dixon, SVP, Global Value & Access, iRhythm
• Sonja Fulmer, Assistant Director for Digital Health Policy, U.S. Food & Drug Administration
• Anitra Graves, MD, Contractor Medical Director, Noridian Healthcare Solutions
• Julie Letwat, Head of Government Affairs, iRhythm Technologies
• Alvin Liu, MD, Assistant Professor, Johns Hopkins University
• Kathryn Marchesini, Chief Privacy Officer, HHS Office of the National Coordinator
• Casey Quinn, Professional Staff, House Ways & Means Committee
• Conor Sheehey, Senior Health Policy Advisor, Senate Finance Committee
• Bodo Wiegand, Senior Advisor, Viopsy

Recent AI thought leadership

• Global artificial intelligence trends guide
• The next era of digital therapeutics
• A brave new world of AI liability in the EU
• EU Lawmaker proposes to regulate generative AI – among other significant changes to the forthcoming AI Act
• AI & Data Regulation: What privacy professionals need to know about the EU, UK, and U.S. approaches 
• Re-use of health data to train algorithms: European Union EDHS Proposal
• HHS ONC proposes new AI / ML requirements for certified Health IT
• FDA promotes pre-approval for changes to AI devices via Predetermined Change Control Plans
• CMS AppliedVR decision shows innovative tech can secure payment pathway under Medicare’s rigid statute
• FDA M-CERSI AI workshop highlights future FDA comment period on AI in drug development
• LS&HC Horizons Guide – Digital Health and AI